If you have been told that the surface of your eye is damaged and that you may need a stem cell transplant, it is completely natural to feel anxious. Words like “stem cell” and “transplant” sound frightening, and you may be worrying about pain, about whether your sight can come back, and about what the surgery actually involves. This page is written to answer those worries honestly, one at a time, alongside clear information about what limbal stem cell deficiency is and how it is treated. The aim is simple: by the end, you should understand your condition and the treatment well enough to feel calm and in control.
Here is the reassuring starting point. The kind of stem cells involved here are not laboratory or embryonic stem cells, and the treatment is not experimental science. These are your eye’s own natural repair cells, the cells that normally keep the front surface of your eye clear and healthy. When they are lost, the eye’s surface breaks down, but in many cases these cells can be restored using a small, well-established operation. The most widely used technique, called SLET, was developed in India and is performed by corneal surgeons here with good results.
“Does a stem cell transplant mean a major, experimental operation on my eye?” No. This is not experimental gene therapy or a whole-eye operation. In the most common technique, a tiny piece of healthy tissue is taken from your own other eye and placed on the damaged surface, where its stem cells regrow the clear surface. It is usually done in under an hour, and it uses your body’s own cells, so the risk of rejection is low. |
Quick answer Limbal stem cell deficiency (LSCD) is a condition in which the eye loses the special repair cells, called limbal stem cells, that keep the clear front surface of the cornea healthy. Without them, the cornea’s surface cannot renew itself properly. It becomes rough, cloudy and covered by the wrong kind of tissue, which causes pain, redness, light sensitivity and blurred or failing vision. |
To understand LSCD, it helps to know a small piece of eye anatomy. The cornea is the clear, dome-shaped window at the very front of the eye. Its outer surface is a thin skin-like layer called the epithelium, and like the skin on your body, this layer is constantly wearing away and being replaced. The cells that replace it do not come from the cornea itself. They come from a narrow ring of tissue at the very edge of the cornea, where the clear cornea meets the white of the eye. This border ring is called the limbus.
The limbus is where the limbal stem cells live. Think of them as a permanent factory sitting around the rim of the cornea, quietly producing fresh surface cells that migrate inward to keep the whole cornea smooth and clear. These stem cells do two vital jobs at once. First, they constantly resurface the cornea so it stays transparent. Second, they act as a fence, holding back the conjunctiva, the pinkish, blood-vessel-rich tissue that covers the white of the eye, and stopping it from creeping across the clear cornea where it does not belong.
In limbal stem cell deficiency, this factory is damaged or destroyed, in part of the eye or all the way around. With the stem cells gone, two things happen. The cornea can no longer resurface itself, so its surface breaks down and will not heal. And with the fence broken, the conjunctiva grows over the cornea, bringing blood vessels and scar tissue onto the normally clear window. The result is a cornea that turns hazy, red and rough, with sight dropping, sometimes severely, and often a gritty, painful, light-sensitive eye.
Why glasses or a normal cornea transplant may not fix it If the stem cells are missing, simply replacing the cornea with a donor cornea often fails, because the new cornea has no healthy stem cells at its edge to keep its surface alive, and it clouds over again. This is why the stem cells themselves have to be restored first. It is the key reason LSCD is treated differently from other corneal problems. |
Doctors describe LSCD as either unilateral (one eye affected, the other healthy) or bilateral (both eyes affected). This single point shapes the whole treatment plan, so it is worth understanding early:
“If both my eyes are affected, is there any hope?” Yes. Bilateral disease is harder to treat, but it is not untreatable. Stem cells can be taken from a matched living relative or from donor tissue, and newer techniques are improving results. The right approach depends on your eyes, which is exactly what a corneal specialist consultation is for. |
Quick answer The most common cause of LSCD is a chemical or heat burn to the eye, which destroys the stem cells at the limbus. Other causes include severe allergic and immune conditions such as Stevens-Johnson syndrome and ocular pemphigoid, the genetic condition aniridia, long-term contact lens overwear, repeated eye surgeries or severe infections, and radiation. In some cases no clear cause is found. |
Limbal stem cells can be lost in two broad ways: they can be destroyed by an injury or burn, or they can fail gradually because of disease, inflammation or a genetic problem. Knowing the cause matters, because it guides which treatment is safest and most likely to work. The main causes are:
Quick answer LSCD causes a red, irritated, light-sensitive eye with blurred or declining vision. People often describe constant watering, a gritty foreign-body feeling, pain or discomfort, and repeated episodes of the surface breaking down. As it advances, the clear cornea looks hazy and may develop a visible skin of pinkish tissue and blood vessels growing across it. |
The symptoms of LSCD come from the surface of the eye breaking down and the wrong tissue growing over the cornea. They can be mild at first and slowly worsen, or, after a burn, appear quite quickly. Common symptoms include:
When to see a specialist quickly Any chemical splash to the eye is an emergency: rinse the eye immediately with plenty of clean water for at least several minutes and get to an eye hospital. And any eye that stays red, painful and light-sensitive with falling vision needs a proper corneal assessment rather than repeated courses of drops. |
Quick answer A corneal specialist diagnoses LSCD by examining the eye’s surface under a microscope (slit lamp), often using a harmless dye that stains the areas where the wrong kind of cells have grown over the cornea. The pattern of staining, the loss of the normal limbal landmarks, and the growth of conjunctiva and blood vessels onto the cornea together confirm the diagnosis. |
Diagnosing LSCD is mainly clinical, meaning it is based on a careful examination by an eye surgeon experienced in corneal disease, supported by a few simple tests. The specialist will take your history, especially any burn, chemical injury, contact lens use, or severe illness like SJS, and then examine the eye. The key steps include:
An important part of the assessment is working out how much of the limbus is damaged (partial or total) and whether one or both eyes are involved, because this decides which treatment is right for you.
Quick answer Treatment depends on how severe the LSCD is. Mild cases may settle with medicines and protecting the surface. When the stem cells are significantly lost, they have to be replaced with a stem cell transplant. For one damaged eye, cells come from your own healthy eye (the SLET technique is the most common). For both eyes, cells come from a donor. A cloudy cornea may need a cornea transplant afterwards, once the surface is healthy. |
There is a ladder of treatment for LSCD, from simple supportive care for mild cases up to stem cell transplantation for severe loss. The right rung depends on how much of the limbus is damaged and whether one or both eyes are affected. Treatment generally falls into these stages:
1. Medical and supportive treatment (for milder or early cases)
If the deficiency is mild, especially contact lens-related LSCD caught early, the first step is to remove the cause and support the surface so it can recover. This can include stopping contact lens wear completely, lubricating drops and ointments, treating any inflammation with anti-inflammatory drops, and sometimes protecting the surface with a special contact lens or by temporarily closing part of the eyelid. In early contact-lens-related cases, the surface can sometimes recover without surgery.
2. Stem cell transplantation (for significant stem cell loss)
When too many stem cells are gone for the surface to recover on its own, the stem cells have to be restored. This is the core treatment for moderate-to-severe LSCD, and it is where techniques like SLET come in. The source of the stem cells depends on whether one or both eyes are affected:
3. Cornea transplant, if the cornea itself is scarred
Restoring the stem cells makes the surface healthy again, but if the deeper cornea is already scarred and cloudy from the original injury, a cornea transplant (keratoplasty) may be needed afterwards to restore clear vision. The important rule is the order: the stem cells are restored first and the surface allowed to stabilise, and only then is the cornea transplant done. Doing both at the same time is generally avoided, because the transplant is far more likely to succeed on a surface that already has healthy stem cells.
The key principle in plain terms You cannot lay new clear glass (a cornea transplant) over a surface that has no cells to keep it alive. First you rebuild the cells at the rim (the stem cell transplant). Then, if needed, you replace the window (the cornea transplant). Getting this order right is what gives the best chance of lasting clear vision. |
Quick answer SLET (Simple Limbal Epithelial Transplantation) is a modern stem cell transplant for a single damaged eye. A small 2 x 2 mm piece of limbal tissue is taken from your healthy eye, cut into several tiny pieces, and spread over the damaged cornea on top of a thin biological membrane, held in place with a tissue glue. Over a few weeks, the stem cells in these pieces grow and resurface the whole cornea. Because the tissue is your own, rejection is not a concern. |
SLET is the most widely used stem cell transplant technique for one-sided LSCD today. It was developed by Indian corneal surgeons and has become popular worldwide because it is simpler, needs only a very small piece of donor tissue, and uses a single operation. Here is what the procedure actually involves, step by step, in plain terms:
Over the following weeks, the stem cells from those tiny pieces multiply and their healthy cells spread out and join up, resurfacing the entire cornea with the correct, clear type of cell, and pushing back the conjunctiva. The eye’s surface becomes smooth, clear and stable again.
“Will taking tissue from my good eye harm it?” The piece taken is very small, and studies following patients over time have found that the healthy donor eyes did not develop stem cell deficiency afterwards. Your surgeon takes tissue from the upper edge, which is protected by the eyelid, and the eye heals. Protecting your good eye is a priority throughout. |
SLET is the most common, but your surgeon may mention other names. They all share the same goal, restoring the stem cells, and differ mainly in where the cells come from and how they are prepared:
Quick answer For one-sided LSCD treated with SLET, published studies report that a stable, clear, healthy corneal surface is restored in roughly three out of four eyes, with most of those eyes also gaining meaningful improvement in vision. Results are best when the surgery is done by an experienced corneal surgeon, when only one eye is affected, and when there is no severe deep scarring or other complicating injury. |
It is natural to want to know the odds before any eye surgery. For SLET in carefully selected patients with one-sided LSCD, the published evidence is encouraging:
As with any surgery, success is not guaranteed for everyone. Outcomes are poorer when the original injury was very severe, when there is heavy eyelid scarring, when an acid injury has caused deep damage, or when a cornea transplant is attempted at the same time rather than afterwards. Your surgeon will give you a realistic picture for your particular eye at your consultation.
A note on the numbers The figures above come from published medical studies of SLET. They describe groups of patients, not a promise for any one person. Your own outlook depends on the cause and severity of your LSCD, whether one or both eyes are affected, and the condition of the deeper cornea, all of which are assessed in person. |
Quick answer Most SLET surgery is done as a day procedure or short stay. A protective bandage contact lens is usually worn for about a week. You will use antibiotic and anti-inflammatory (steroid) drops, with the steroid slowly reduced over several weeks. The new surface typically heals over about six weeks, and vision improves gradually after that. Regular follow-up visits are important to check that the surface stays healthy. |
Recovery from a stem cell transplant is gradual, because the new cells need time to grow and cover the cornea. Knowing what to expect helps you plan and reduces worry:
Quick answer SLET is generally safe, and because it uses your own tissue, rejection is not a concern for one-eyed disease. As with any eye surgery, there are some risks: infection, inflammation, the graft pieces not taking fully, or the surface breaking down, which can mean the deficiency is not fully corrected and further treatment is needed. Serious complications are uncommon in experienced hands. |
Being told about risks is not meant to frighten you; it is so you can give informed consent and know what to watch for. The main risks of stem cell transplant surgery include:
What lowers the risks Choosing an experienced corneal surgeon, following the eye-drop schedule exactly, protecting the eye, attending every follow-up, and treating LSCD before attempting any cornea transplant all improve the odds of a smooth recovery and a lasting result. |
No, though the names sound similar. A cornea transplant replaces the clear window of the eye with donor tissue. A stem cell transplant (for LSCD) restores the repair cells at the edge of the cornea so the surface can keep itself healthy. Sometimes both are needed, in which case the stem cells are restored first and the cornea transplant is done later.
If only one eye is affected, they come from a tiny piece of your own healthy eye, so there is no rejection. If both eyes are affected, they come from a matched living relative or from donated tissue, which does require anti-rejection medicines.
The surgery itself is done with anaesthesia so you do not feel pain during it. Afterwards the eye can feel gritty, watery and sore for a few days, which settles, and a protective contact lens and eye drops help with comfort and healing.
The new surface usually heals over about six weeks, and vision improves gradually after that. You will use eye drops during this period and attend regular follow-up visits. If a cornea transplant is needed later, that is planned once the surface is stable.
The piece taken is very small, from the upper edge protected by the eyelid, and studies have found that donor eyes did not develop stem cell deficiency afterwards. Protecting your healthy eye is a priority throughout.
Mild cases, especially those caused by contact lens overwear and caught early, can sometimes recover with medicines, lubrication and stopping the cause. When a significant number of stem cells are lost, surgery to restore them is usually needed.
Untreated, the surface keeps breaking down, the cornea clouds over with scar tissue and blood vessels, and vision can be lost, along with ongoing pain and light sensitivity. Early assessment gives the best chance of saving sight.
